Celene Pharmaceuticals Llp - Due diligence report

A 360° intelligence report on Celene Pharmaceuticals Llp: trust score, financial health, credit view, compliance, directors, growth and dist…

2023-01-03 New Delhi, Delhi Under Process Of Striking Off
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Celene Pharmaceuticals Llp — 360° Intelligence Report

Generated from MCA filings & public records
62/100
Trust Score
Moderate

Celene Pharmaceuticals Llp is assessed as Moderate with a Trust Score of 62/100. Celene Pharmaceuticals Llp is a limited liability partnership incorporated in 2023, operating in the Business Services sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.

Report generated on 18 Oct 2026 from the latest processed filings. Celene Pharmaceuticals Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 45/100 Caution Indicated
  • Company status is "Under Process Of Striking Off" - not Active.
  • No balance-sheet filing date on record.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
AMRITANSHU RANJAN 01234567 Director 01/04/2018 6 yrs Approved
AVANI RANJAN 01234567 Director 01/04/2018 6 yrs Approved
RAKESH KUMAR 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 65
Growth signals & trust indicators
Young company (3 years).
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Adverse company status: Under Process Of Striking Off.
Compliance score is weak (45/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence56/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • No financials on record - ask for audited statements.
Banker assessment55/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view42/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 5 events
31 Mar 2024
Last AGM held
Annual general meeting
03 Jan 2023
Incorporated
Registered with Roc Delhi
Director appointed
AMRITANSHU RANJAN (Designated Partner)
Director appointed
AVANI RANJAN (Designated Partner)
Director appointed
RAKESH KUMAR (Designated Partner)
10

Key Observations

Auto-generated from the data above
3 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Mehreen Productions Private Limited U93020DL2017PTC324670 South Delhi, Delhi
Renomp Data And Consulting (Opc) Private Limited U74999DL2021OPC387393 Delhi
Medikriti Tours India Private Limited U74110DL2016PTC307309 Delhi
Bonton Opticians World Private Limited U74899DL1990PTC041715 Delhi
Dates Discs Private Limited U74899DL1945PTC000861 Delhi
Bahl Electronics Private Limited U32109DL2001PTC113436 Delhi
Energia Infrastructures Limited U45400DL2009PLC194728 Delhi
Bynet Telecommunications Private Limited U32204DL2006PTC151951 South Delhi, Delhi
Svf Health Private Limited U74999DL2021PTC383746 Delhi
Charu Medical Services Private Limited. U33112DL1990PTC040514 South Delhi, Delhi
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Celene Pharmaceuticals Llp before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Celene Pharmaceuticals Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Celene Pharmaceuticals Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Celene Pharmaceuticals Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Celene Pharmaceuticals Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Celene Pharmaceuticals Llp an active company?

Celene Pharmaceuticals Llp has MCA status “Under Process Of Striking Off” with a compliance score of 45/100 (Caution Indicated).

Is Celene Pharmaceuticals Llp financially healthy?

Processed financial statements are not yet available for Celene Pharmaceuticals Llp, so its financial health is unassessed.

Should I do business with Celene Pharmaceuticals Llp?

Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Celene Pharmaceuticals Llp?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Celene Pharmaceuticals Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Celene Pharmaceuticals Llp up to date with its ROC filings?

No balance-sheet filing date on record. Overall compliance score: 45/100 (Caution Indicated).

Is it risky to lend to Celene Pharmaceuticals Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.